SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-289308
Filing Date
2019-11-12
Accepted
2019-11-12 08:02:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d829222d424b5.htm 424B5 105704
2 GRAPHIC g829222g22c14.jpg GRAPHIC 66620
3 GRAPHIC g829222g99l65.jpg GRAPHIC 178642
  Complete submission text file 0001193125-19-289308.txt   444691
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-225391 | Film No.: 191206233
SIC: 2834 Pharmaceutical Preparations